WELCH DANIEL G
Transactions
50
Companies
10
Filings
12
CIK
0001206199
Recent Transactions
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Sale
- Exercise/Conversion
- Sale
- Sale
- Exercise/Conversion
- Other
Stock option (right to buy)
2023-08-03$7.97/sh−411,000→ 768,122 total - Other
Stock option (right to buy)
2023-08-03$7.97/sh+205,500→ 205,500 total - Other
Stock option (right to buy)
2023-08-03$7.97/sh+205,500→ 205,500 total - Award
- Award
- Award
- Award
- Exercise/Conversion
- Sale
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Sale
- Sale
- Exercise/Conversion
- Sale
- Exercise/Conversion
- Exercise/Conversion
- Sale
- Exercise/Conversion
- Sale
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Sale
Companies
10AveXis, Inc.
Director
HYPERION THERAPEUTICS INC
Director
INTERCEPT PHARMACEUTICALS, INC.
Director
INTERMUNE INC
Director, CEO and President
- $NUVB
Nuvation Bio Inc.
Director
- $PRTA
PROTHENA CORP PUBLIC LTD CO
Director
Seagen Inc.
Director
- $GPCR
Structure Therapeutics Inc.
Director
TRIANGLE PHARMACEUTICALS INC
Chairman and Chief Executive Officer
- $RARE
Ultragenyx Pharmaceutical Inc.
Director
Recent Filings
12- 4
WELCH DANIEL G
Jun 18, 2026
- 4
WELCH DANIEL G
May 18, 2026
- 4
WELCH DANIEL G
May 15, 2026
- 4
WELCH DANIEL G
Jun 25, 2025
- 4
WELCH DANIEL G
May 19, 2025
- 4
WELCH DANIEL G
May 16, 2025
- 4
WELCH DANIEL G
Jun 27, 2024
- 4
WELCH DANIEL G
Jun 20, 2024
- 4
WELCH DANIEL G
May 29, 2024
- 4
WELCH DANIEL G
May 17, 2024
- 4
WELCH DANIEL G
Feb 23, 2024
- 4
WELCH DANIEL G
Dec 15, 2023
Address
C/O STRUCTURE THERAPEUTICS INC. 601 GATEWAY BLVD., SUITE 900
SOUTH SAN FRANCISCO, CA, 94080